Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IFI30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MT1X - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YBEY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRR34-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFSD11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NME6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CKLF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FUCA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLTP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IVD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C16orf59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506100 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGDIB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRIM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ME3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GCHFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on